483 related articles for article (PubMed ID: 15528789)
1. Development of a fluorescent multiplex assay for detection of MSI-High tumors.
Bacher JW; Flanagan LA; Smalley RL; Nassif NA; Burgart LJ; Halberg RB; Megid WM; Thibodeau SN
Dis Markers; 2004; 20(4-5):237-50. PubMed ID: 15528789
[TBL] [Abstract][Full Text] [Related]
2. A ten markers panel provides a more accurate and complete microsatellite instability analysis in mismatch repair-deficient colorectal tumors.
Agostini M; Enzo MV; Morandi L; Bedin C; Pizzini S; Mason S; Bertorelle R; Urso E; Mescoli C; Lise M; Pucciarelli S; Nitti D
Cancer Biomark; 2010; 6(1):49-61. PubMed ID: 20164541
[TBL] [Abstract][Full Text] [Related]
3. Loci for efficient detection of microsatellite instability in hereditary non-polyposis colorectal cancer.
Frazier ML; Sinicrope FA; Amos CI; Cleary KR; Lynch PM; Levin B; Luthra R
Oncol Rep; 1999; 6(3):497-505. PubMed ID: 10203581
[TBL] [Abstract][Full Text] [Related]
4. Simplified MSI marker panel for diagnosis of colorectal cancer.
Shemirani AI; Haghighi MM; Zadeh SM; Fatemi SR; Taleghani MY; Zali N; Akbari Z; Kashfi SM; Zali MR
Asian Pac J Cancer Prev; 2011; 12(8):2101-4. PubMed ID: 22292659
[TBL] [Abstract][Full Text] [Related]
5. Identification of HNPCC by molecular analysis of colorectal and endometrial tumors.
Vasen HF; Hendriks Y; de Jong AE; van Puijenbroek M; Tops C; Bröcker-Vriends AH; Wijnen JT; Morreau H
Dis Markers; 2004; 20(4-5):207-13. PubMed ID: 15528786
[TBL] [Abstract][Full Text] [Related]
6. Quasimonomorphic mononucleotide repeats for high-level microsatellite instability analysis.
Buhard O; Suraweera N; Lectard A; Duval A; Hamelin R
Dis Markers; 2004; 20(4-5):251-7. PubMed ID: 15528790
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of Iranian colorectal cancer patients at risk for Lynch syndrome: a new molecular, clinicopathological feature.
Zeinalian M; Emami MH; Salehi R; Naimi A; Kazemi M; Hashemzadeh-Chaleshtori M
J Gastrointest Cancer; 2015 Jun; 46(2):118-25. PubMed ID: 25722176
[TBL] [Abstract][Full Text] [Related]
8. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
[TBL] [Abstract][Full Text] [Related]
9. MSI-testing in hereditary non-polyposis colorectal carcinoma (HNPCC).
Müller A; Edmonston TB; Dietmaier W; Büttner R; Fishel R; Rüschoff J
Dis Markers; 2004; 20(4-5):225-36. PubMed ID: 15528788
[TBL] [Abstract][Full Text] [Related]
10. Automated, multiplex assay for high-frequency microsatellite instability in colorectal cancer.
Nash GM; Gimbel M; Shia J; Culliford AT; Nathanson DR; Ndubuisi M; Yamaguchi Y; Zeng ZS; Barany F; Paty PB
J Clin Oncol; 2003 Aug; 21(16):3105-12. PubMed ID: 12915601
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
[TBL] [Abstract][Full Text] [Related]
12. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
[TBL] [Abstract][Full Text] [Related]
13. Microsatellite instability markers for identifying early-onset colorectal cancers caused by germ-line mutations in DNA mismatch repair genes.
Mead LJ; Jenkins MA; Young J; Royce SG; Smith L; St John DJ; Macrae F; Giles GG; Hopper JL; Southey MC
Clin Cancer Res; 2007 May; 13(10):2865-9. PubMed ID: 17504984
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite instability and DNA mismatch repair deficiency testing in hereditary and sporadic gastrointestinal cancers.
Gologan A; Sepulveda AR
Clin Lab Med; 2005 Mar; 25(1):179-96. PubMed ID: 15749237
[TBL] [Abstract][Full Text] [Related]
15. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer.
Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY
Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581
[TBL] [Abstract][Full Text] [Related]
16. T25 repeat in the 3' untranslated region of the CASP2 gene: a sensitive and specific marker for microsatellite instability in colorectal cancer.
Findeisen P; Kloor M; Merx S; Sutter C; Woerner SM; Dostmann N; Benner A; Dondog B; Pawlita M; Dippold W; Wagner R; Gebert J; von Knebel Doeberitz M
Cancer Res; 2005 Sep; 65(18):8072-8. PubMed ID: 16166278
[TBL] [Abstract][Full Text] [Related]
17. Molecular screening of potential HNPCC patients using a multiplex microsatellite PCR system.
Sutter C; Gebert J; Bischoff P; Herfarth C; von Knebel Doeberitz M
Mol Cell Probes; 1999 Apr; 13(2):157-65. PubMed ID: 10208807
[TBL] [Abstract][Full Text] [Related]
18. Microsatellite instability analysis and/or immunostaining for the diagnosis of hereditary nonpolyposis colorectal cancer?
Halvarsson B; Lindblom A; Rambech E; Lagerstedt K; Nilbert M
Virchows Arch; 2004 Feb; 444(2):135-41. PubMed ID: 14652751
[TBL] [Abstract][Full Text] [Related]
19. Molecular testing for microsatellite instability and DNA mismatch repair defects in hereditary and sporadic colorectal cancers--ready for prime time?
Søreide K
Tumour Biol; 2007; 28(5):290-300. PubMed ID: 17962726
[TBL] [Abstract][Full Text] [Related]
20. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
Boland CR; Thibodeau SN; Hamilton SR; Sidransky D; Eshleman JR; Burt RW; Meltzer SJ; Rodriguez-Bigas MA; Fodde R; Ranzani GN; Srivastava S
Cancer Res; 1998 Nov; 58(22):5248-57. PubMed ID: 9823339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
